Osiris jumps after earnings beat Street
Osiris Therapeutics Inc. (NASDAQ:OSIR) jumped $2.44 (35%) to $9.35 on Wednesday after reporting earnings that beat the Street. The stock move translates to an $80.2 million gain in market cap for a closing valuation of $307.4 million. Osiris reported a 4Q12 diluted loss per share of $0.08, narrower than the Street's estimate of a loss per share of $0.15. The company reported diluted EPS of $0.15 in 4Q11. Osiris also reported $3.1 million in revenues for the quarter, beating the Street's $2.9 million estimate and up 36% from 4Q11. Biosurgery product revenues, which include wound healing product Grafix, were $2.9 million in the quarter compared with $800,000 in the same period in 2011. Grafix is a 3D cellular matrix that includes endogenous mesenchymal stem cells (MSCs) and growth factors to promote wound healing. ...